Brazil studies tissue-eng replacement of cardiac surgery
This article was originally published in Clinica
The Brazilian government is confident that tissue-regeneration using autologous stem cells can provide a viable alternative to heart transplants and other cardiac interventions. The health ministry is setting aside R$13m (US$4.5m) to conduct a study of around 1,200 patients, with the aim of establishing just how efficient the technology could be.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.